Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ADOBE INC.ADBE · Entity 2895 | Director | April 15, 2026 | April 17, 2026 |
| CLOROX CO /DE/CLX · Entity 3474 | Director | September 30, 2024 | October 02, 2024 |
| LENNAR CORP /NEW/LEN, LEN.B · Entity 1032 | Director | October 07, 2026 | October 08, 2026 |
| On Holding AGONON · Entity 3565 | Director | September 21, 2026 | September 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ADOBE INC.
Report date April 15, 2026 · Filed April 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,462 |
Reported balance
After 2026-04-15 transaction · row 1
1 source rowRow 1 · 2026-04-15 · Exercise / conversion · Acquired 900 · Balance 34,462 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-04-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-15 · Exercise / conversion · Disposed 900 · Balance 0 F2: This restricted stock unit award vested in full on April 15, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,367 |
Reported balance
After 2026-04-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-15 · Grant · Acquired 1,367 · Balance 1,367 F3: Vests 100% on the day of the Issuer's next annual meeting of stockholders. |
| Common StockSEC Table I · non-derivative | Indirectby trust | 55 |
Reported balance
Holding disclosure · report date 2026-04-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 55 F1: Shares held by the 2000 Crummey Trust for the benefit of the son of the Reporting Person, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held by the 2000 Crummey Trust for the benefit of the son of the Reporting Person, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any.
F2: This restricted stock unit award vested in full on April 15, 2026.
F3: Vests 100% on the day of the Issuer's next annual meeting of stockholders.
CLOROX CO /DE/
Report date September 30, 2024 · Filed October 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 524 |
Reported balance
After 2024-09-30 transaction · row 1
1 source rowRow 1 · 2024-09-30 · Grant · Acquired 161 · Balance 524 F1: Receipt of Common Stock in lieu of quarterly director's fee. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,031.4878 |
Reported balance
After 2024-08-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-08-30 · Grant · Acquired 61.4205 · Balance 8,031.4878 F2: 1-for-1 F3: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: Receipt of Common Stock in lieu of quarterly director's fee.
F2: 1-for-1
F3: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
LENNAR CORP /NEW/
Report date October 07, 2026 · Filed October 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 16,977 |
Reported balance
After 2026-10-07 transaction · row 1
1 source rowRow 1 · 2026-10-07 · Grant · Acquired 15 · Balance 16,977 F1: Represents restricted stock units ("RSUs") issued in respect of the Reporting Person's unvested annual RSU grant (including dividend equivalents in respect thereof) as a result of the dividend on the Issuer's common stock with a record date of October 7, 2026, in accordance with the Issuer's outside directors' compensation program. Such RSUs will vest at the same time as the annual RSU grant to which they relate. Fractional amounts have been rounded to the nearest whole number. F2: Represents the closing price per share of Issuer's common stock as of the record date. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Trust | 165 |
Reported balance
Holding disclosure · report date 2026-10-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 165 F3: These shares are held in a trust, of which the reporting person is the trustee, for the benefit of the reporting person's child. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") issued in respect of the Reporting Person's unvested annual RSU grant (including dividend equivalents in respect thereof) as a result of the dividend on the Issuer's common stock with a record date of October 7, 2026, in accordance with the Issuer's outside directors' compensation program. Such RSUs will vest at the same time as the annual RSU grant to which they relate. Fractional amounts have been rounded to the nearest whole number.
F2: Represents the closing price per share of Issuer's common stock as of the record date.
F3: These shares are held in a trust, of which the reporting person is the trustee, for the benefit of the reporting person's child.
On Holding AG
Report date September 21, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A SharesSEC Table I · non-derivative | Direct | 81,914 |
Reported balance
After 2026-09-21 transaction · row 1
1 source rowRow 1 · 2026-09-21 · Grant · Acquired 2,433 · Balance 81,914 F1: On September 21, 2026, the Reporting Person was granted 2,433 restricted stock units, which vested into Class A Shares immediately after the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 21, 2026, the Reporting Person was granted 2,433 restricted stock units, which vested into Class A Shares immediately after the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 963.0341 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000381 · doc4.xml · derivative · entry 5 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,316.677 Underlying: Common Stock · 963.0341 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 16, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 7.9734 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000381 · doc4.xml · derivative · entry 4 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,353.6429 Underlying: Common Stock · 7.9734 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 17, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 8.6999 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000381 · doc4.xml · derivative · entry 3 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,345.6695 Underlying: Common Stock · 8.6999 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 11, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 10.5637 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000381 · doc4.xml · derivative · entry 2 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,336.9696 Underlying: Common Stock · 10.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| April 13, 2018 Filed Apr 13, 2018 20:21 UTC | ADOBE INC. ADBE · Entity 2895 | GrantRestricted Stock Units · Derivative | 1,177 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000796343-18-000092 · wf-form4_152365089787776.xml · derivative · entry 3 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,177 Underlying: Common Stock · 1,177 shares Expires not disclosed F2 · derivative.exercise_date: Vests 100% on the day preceding the Issuer's next annual meeting of stockholders. F2 · derivative.expiration_date: Vests 100% on the day preceding the Issuer's next annual meeting of stockholders. Read SEC document |
| April 13, 2018 Filed Apr 19, 2024 20:14 UTC Amendment | ADOBE INC. ADBE · Entity 2895 | GrantRestricted Stock Units · Derivative | 1,177 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000796343-24-000087 · wk-form4a_1713557670.xml · derivative · entry 3 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,177 Underlying: Common Stock · 1,177 shares Expires not disclosed F2 · derivative.exercise_date: Vests 100% on the day preceding the Issuer's next annual meeting of stockholders. F2 · derivative.expiration_date: Vests 100% on the day preceding the Issuer's next annual meeting of stockholders. Read SEC document |
| April 11, 2018 Filed Apr 13, 2018 20:21 UTC | ADOBE INC. ADBE · Entity 2895 | Exercise / conversionRestricted Stock Units · Derivative | 2,035 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000796343-18-000092 · wf-form4_152365089787776.xml · derivative · entry 2 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,035 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on April 11, 2018. F1 · derivative.expiration_date: This restricted stock unit award vested in full on April 11, 2018. Read SEC document |
| April 11, 2018 Filed Apr 13, 2018 20:21 UTC | ADOBE INC. ADBE · Entity 2895 | Exercise / conversionCommon Stock | 2,035 | $0.00 | $0.00 |
DisclosureSEC source: 0000796343-18-000092 · wf-form4_152365089787776.xml · nonDerivative · entry 1 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 11, 2018 Filed Apr 19, 2024 20:14 UTC Amendment | ADOBE INC. ADBE · Entity 2895 | Exercise / conversionRestricted Stock Units · Derivative | 2,035 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000796343-24-000087 · wk-form4a_1713557670.xml · derivative · entry 2 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,035 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on April 11, 2018. F1 · derivative.expiration_date: This restricted stock unit award vested in full on April 11, 2018. Read SEC document |
| April 11, 2018 Filed Apr 19, 2024 20:14 UTC Amendment | ADOBE INC. ADBE · Entity 2895 | Exercise / conversionCommon Stock | 2,035 | $0.00 | $0.00 |
DisclosureSEC source: 0000796343-24-000087 · wk-form4a_1713557670.xml · nonDerivative · entry 1 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2018 Filed Jan 3, 2019 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 8.5944 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000381 · doc4.xml · derivative · entry 1 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,326.4059 Underlying: Common Stock · 8.5944 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,002.0689 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000434 · doc4.xml · derivative · entry 5 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,317.8115 Underlying: Common Stock · 1,002.0689 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 18, 2017 Filed Dec 19, 2017 21:33 UTC | ADOBE INC. ADBE · Entity 2895 | PurchaseCommon Stock | 1,125 | $177.35 | $199,519.54 |
DisclosureSEC source: 0000796343-17-000192 · wf-form4_151371920690917.xml · nonDerivative · entry 1 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,453 F1 · price: This transaction was executed in multiple trades at prices ranging from $175.62 to $178.42. The price reported above reflects the weighted average execution price. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| November 13, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1.9513 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000434 · doc4.xml · derivative · entry 4 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315.7425 Underlying: Common Stock · 1.9513 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| October 23, 2017 Filed Dec 5, 2017 23:06 UTC | ADOBE INC. ADBE · Entity 2895 | GiftCommon Stock | 264 | $0.00 | $0.00 |
DisclosureSEC source: 0000796343-17-000177 · wf-form5_151251516804767.xml · nonDerivative · entry 1 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,328 F1 · price: Shares transferred as bona fide gifts without any consideration. Read SEC document |
| August 04, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1.9477 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000434 · doc4.xml · derivative · entry 3 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313.7912 Underlying: Common Stock · 1.9477 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 05, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1.8661 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000434 · doc4.xml · derivative · entry 2 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311.8435 Underlying: Common Stock · 1.8661 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| April 13, 2017 Filed Apr 13, 2017 20:12 UTC | ADOBE INC. ADBE · Entity 2895 | GrantRestricted Stock Units · Derivative | 2,035 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000796343-17-000101 · wf-form4_149211436230761.xml · derivative · entry 3 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,035 Underlying: Common Stock · 2,035 shares Expires not disclosed F2 · derivative.exercise_date: Vests 100% on the day preceding the Issuer's next annual meeting of stockholders. F2 · derivative.expiration_date: Vests 100% on the day preceding the Issuer's next annual meeting of stockholders. Read SEC document |
| April 11, 2017 Filed Apr 13, 2017 20:12 UTC | ADOBE INC. ADBE · Entity 2895 | Exercise / conversionRestricted Stock Units · Derivative | 2,801 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000796343-17-000101 · wf-form4_149211436230761.xml · derivative · entry 2 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,801 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on April 11, 2017. F1 · derivative.expiration_date: This restricted stock unit award vested in full on April 11, 2017. Read SEC document |
| April 11, 2017 Filed Apr 13, 2017 20:12 UTC | ADOBE INC. ADBE · Entity 2895 | Exercise / conversionCommon Stock | 2,801 | $0.00 | $0.00 |
DisclosureSEC source: 0000796343-17-000101 · wf-form4_149211436230761.xml · nonDerivative · entry 1 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1.9399 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000434 · doc4.xml · derivative · entry 1 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309.9774 Underlying: Common Stock · 1.9399 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 308.0375 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000366 · doc4.xml · derivative · entry 1 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308.0375 Underlying: Common Stock · 308.0375 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.